HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Autosomal Dominant 2A Deafness

Also Known As:

Deafness, Autosomal Dominant 2A; DFNA2A

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Disease Context: Research Results

Related Diseases

1.	Hearing Loss (Hearing Impairment)
2.	Deafness (Deaf Mutism)

Experts

1.	An, Xiaogang: 1 article (01/2021)
2.	Chen, Jun: 1 article (01/2021)
3.	Li, Qiong: 1 article (01/2021)
4.	Li, Wei: 1 article (01/2021)
5.	Liang, Pengfei: 1 article (01/2021)
6.	Wang, Jian: 1 article (01/2021)
7.	Wang, Shujuan: 1 article (01/2021)
8.	Yang, Yang: 1 article (01/2021)
9.	Zha, Dingjun: 1 article (01/2021)
10.	Akbari, Mojdeh: 1 article (01/2019)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Autosomal Dominant 2A Deafness:

1.	Potassium Channels (Potassium Channel)IBA 01/01/2019 - "The KCNQ4 gene (DFNA2A) encodes a potassium channel (KV7.4) and the heterozygous variant identified (c.1647C>G, p.F549L) resulted in the substitution of Phe549 residing in the KV7.4 cytoplasmic region. "
2.	PotassiumIBA 01/01/2021 - "Variants in potassium voltage‑gated channel subfamily Q member 4 (KCNQ4) are etiologically linked to a type of progressive hearing loss, deafness non‑syndromic autosomal dominant 2A (DFNA2A). "

Therapies and Procedures

1.	Therapeutics 01/01/2021 - "The present study has added to the number of pathogenic variants observed in the KCNQ4 gene, and the findings may prove to be useful for both the diagnosis of DFNA2A and in the design of early interventional therapies."